Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineered human vaccines

J S Sandhu1

  • 1Division of Immunology and Neurobiology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada.

Critical Reviews in Biotechnology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STELA (Smart TV and smartphone-basEd Laparoscopy TrAiner): a no-cost home-based trainer for beginners.

Medical journal, Armed Forces India·2021
Same author

Safety and efficacy of total intraluminal topical anaesthesia for ureteroscopy. Is success worth the pain?

Medical journal, Armed Forces India·2019
Same author

Effect of Hemodialysis on Corrected QT Interval and QTc Dispersion.

Indian journal of nephrology·2018
Same author

Assessment of vestibular function in patients with chronic middle ear disease using the VHIT and VEMP test.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2018
Same author

Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2018
Same author

Double trouble: Concomitant infection of esophagus by Herpes and Candida in diabetic, non HIV patients-Report of two cases.

Diagnostic cytopathology·2017
Same journal

Sustainable and green novel sorbent-based immobilization of PFAS and their enhanced adsorption to treat environmental contamination.

Critical reviews in biotechnology·2026
Same journal

Advances, challenges, and opportunities in engineering C5 and C6 sugar transporters in yeast for bio-based industrial biotechnology.

Critical reviews in biotechnology·2026
Same journal

Microbial engineering for the conversion of C1 feedstocks into value-added bioproducts: recent advances and perspectives.

Critical reviews in biotechnology·2026
Same journal

A step forward toward improved cold tolerance in rice: integrating physiological insights with cutting-edge genomic approaches.

Critical reviews in biotechnology·2026
Same journal

Emerging role of nanotechnology in the protection of BT biopesticide from UV radiations.

Critical reviews in biotechnology·2026
Same journal

Tuning molecular weight of poly-γ-glutamic acid: advanced biosynthetic engineering approaches and diversified applications.

Critical reviews in biotechnology·2026
See all related articles

Current human vaccines have limitations. This review discusses engineered vaccines for infectious diseases and cancer, highlighting future developments and the need for novel adjuvants.

Area of Science:

  • Vaccinology
  • Biotechnology
  • Immunology

Background:

  • Existing human vaccines face limitations in efficacy and scope.
  • There is a continuous need for advanced vaccine technologies to address global health challenges.
  • Engineered vaccines represent a promising frontier in disease prevention.

Purpose of the Study:

  • To review the progress of engineered human vaccines against bacteria, viruses, parasites, and cancer.
  • To discuss human study data, particularly for cancer and AIDS vaccines.
  • To explore future directions and the role of adjuvants in vaccine development.

Main Methods:

  • Literature review of current vaccine engineering strategies.
  • Analysis of human trial data for engineered vaccines.

Related Experiment Videos

  • Discussion of technological advancements and future prospects.

    • Main Results:

    • Engineered vaccines show progress in development for various pathogens and cancer.
    • Human studies, especially for cancer and AIDS vaccines, provide valuable insights.
    • The development of effective adjuvants is crucial for enhancing vaccine performance.

    Conclusions:

    • Engineered vaccines offer potential improvements over current vaccine technologies.
    • Further research into vaccine design, human studies, and adjuvant development is essential.
    • The field of engineered human vaccines is poised for significant future advancements.